Cargando…

Cytogenomic features of Richter transformation

BACKGROUND: Richter transformation (RT) is the development of aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This rare disease is characterised by dismal prognosis. In recent years, there has been a deeper understanding of RT molecular pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Woroniecka, Renata, Rymkiewicz, Grzegorz, Bystydzienski, Zbigniew, Pienkowska-Grela, Barbara, Rygier, Jolanta, Malawska, Natalia, Wojtkowska, Katarzyna, Goral, Nikolina, Blachnio, Katarzyna, Chmielewski, Marcin, Bartnik-Glaska, Magdalena, Grygalewicz, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631075/
https://www.ncbi.nlm.nih.gov/pubmed/37941034
http://dx.doi.org/10.1186/s13039-023-00662-0
_version_ 1785132292520280064
author Woroniecka, Renata
Rymkiewicz, Grzegorz
Bystydzienski, Zbigniew
Pienkowska-Grela, Barbara
Rygier, Jolanta
Malawska, Natalia
Wojtkowska, Katarzyna
Goral, Nikolina
Blachnio, Katarzyna
Chmielewski, Marcin
Bartnik-Glaska, Magdalena
Grygalewicz, Beata
author_facet Woroniecka, Renata
Rymkiewicz, Grzegorz
Bystydzienski, Zbigniew
Pienkowska-Grela, Barbara
Rygier, Jolanta
Malawska, Natalia
Wojtkowska, Katarzyna
Goral, Nikolina
Blachnio, Katarzyna
Chmielewski, Marcin
Bartnik-Glaska, Magdalena
Grygalewicz, Beata
author_sort Woroniecka, Renata
collection PubMed
description BACKGROUND: Richter transformation (RT) is the development of aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This rare disease is characterised by dismal prognosis. In recent years, there has been a deeper understanding of RT molecular pathogenesis, and disruptions of apoptosis (TP53) and proliferation (CDKN2A, MYC, NOTCH1) has been described as typical aberrations in RT. RESULTS: A single-institution cohort of 33 RT patients were investigated by karyotyping, fluorescence in situ hybridization and single nucleotide polymorphism/copy number (CN) arrays. Most of RTs were typically manifested by diffuse large B-cell lymphoma, not otherwise specified, among the remaining cases one was classified as high-grade B-cell lymphoma with 11q aberrations. The most frequent alterations (40–60% of cases) were represented by MYC rearrangement/gain, deletions of TP53 and CDKN2A, IGH rearrangement and 13q14 deletion. Several other frequent lesions included losses of 14q24.1-q32.33, 7q31.33-q36.3, and gain of 5q35.2. Analysis of 13 CLL/SLL-RT pairs showed that RT arised from the CLL/SLL by acquiring of 10 ~ 12 cytogenetic or CN lesions/case, but without acquisition of loss of heterozygosity regions. Our result affirmed the higher genetic complexity in RT than CLL/SLL and confirmed the linear features of RT clonal evolution as predominant. CONCLUSIONS: Cytogenomic profile was concordant with the literature data, however the role of IGH rearrangement, 14q deletion and 5q35.2 gain need to be explored. We anticipate that further characterization of RT lesions will probably facilitate better understanding of the RT clonal evolution. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13039-023-00662-0.
format Online
Article
Text
id pubmed-10631075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106310752023-11-08 Cytogenomic features of Richter transformation Woroniecka, Renata Rymkiewicz, Grzegorz Bystydzienski, Zbigniew Pienkowska-Grela, Barbara Rygier, Jolanta Malawska, Natalia Wojtkowska, Katarzyna Goral, Nikolina Blachnio, Katarzyna Chmielewski, Marcin Bartnik-Glaska, Magdalena Grygalewicz, Beata Mol Cytogenet Research BACKGROUND: Richter transformation (RT) is the development of aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This rare disease is characterised by dismal prognosis. In recent years, there has been a deeper understanding of RT molecular pathogenesis, and disruptions of apoptosis (TP53) and proliferation (CDKN2A, MYC, NOTCH1) has been described as typical aberrations in RT. RESULTS: A single-institution cohort of 33 RT patients were investigated by karyotyping, fluorescence in situ hybridization and single nucleotide polymorphism/copy number (CN) arrays. Most of RTs were typically manifested by diffuse large B-cell lymphoma, not otherwise specified, among the remaining cases one was classified as high-grade B-cell lymphoma with 11q aberrations. The most frequent alterations (40–60% of cases) were represented by MYC rearrangement/gain, deletions of TP53 and CDKN2A, IGH rearrangement and 13q14 deletion. Several other frequent lesions included losses of 14q24.1-q32.33, 7q31.33-q36.3, and gain of 5q35.2. Analysis of 13 CLL/SLL-RT pairs showed that RT arised from the CLL/SLL by acquiring of 10 ~ 12 cytogenetic or CN lesions/case, but without acquisition of loss of heterozygosity regions. Our result affirmed the higher genetic complexity in RT than CLL/SLL and confirmed the linear features of RT clonal evolution as predominant. CONCLUSIONS: Cytogenomic profile was concordant with the literature data, however the role of IGH rearrangement, 14q deletion and 5q35.2 gain need to be explored. We anticipate that further characterization of RT lesions will probably facilitate better understanding of the RT clonal evolution. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13039-023-00662-0. BioMed Central 2023-11-08 /pmc/articles/PMC10631075/ /pubmed/37941034 http://dx.doi.org/10.1186/s13039-023-00662-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Woroniecka, Renata
Rymkiewicz, Grzegorz
Bystydzienski, Zbigniew
Pienkowska-Grela, Barbara
Rygier, Jolanta
Malawska, Natalia
Wojtkowska, Katarzyna
Goral, Nikolina
Blachnio, Katarzyna
Chmielewski, Marcin
Bartnik-Glaska, Magdalena
Grygalewicz, Beata
Cytogenomic features of Richter transformation
title Cytogenomic features of Richter transformation
title_full Cytogenomic features of Richter transformation
title_fullStr Cytogenomic features of Richter transformation
title_full_unstemmed Cytogenomic features of Richter transformation
title_short Cytogenomic features of Richter transformation
title_sort cytogenomic features of richter transformation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631075/
https://www.ncbi.nlm.nih.gov/pubmed/37941034
http://dx.doi.org/10.1186/s13039-023-00662-0
work_keys_str_mv AT woronieckarenata cytogenomicfeaturesofrichtertransformation
AT rymkiewiczgrzegorz cytogenomicfeaturesofrichtertransformation
AT bystydzienskizbigniew cytogenomicfeaturesofrichtertransformation
AT pienkowskagrelabarbara cytogenomicfeaturesofrichtertransformation
AT rygierjolanta cytogenomicfeaturesofrichtertransformation
AT malawskanatalia cytogenomicfeaturesofrichtertransformation
AT wojtkowskakatarzyna cytogenomicfeaturesofrichtertransformation
AT goralnikolina cytogenomicfeaturesofrichtertransformation
AT blachniokatarzyna cytogenomicfeaturesofrichtertransformation
AT chmielewskimarcin cytogenomicfeaturesofrichtertransformation
AT bartnikglaskamagdalena cytogenomicfeaturesofrichtertransformation
AT grygalewiczbeata cytogenomicfeaturesofrichtertransformation